Kin Meds vs MedLeanRx
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Compounded and brand-name GLP-1 plus a longevity stack on one platform.
- semaglutide
- $149/mobrand-name
- tirzepatide
- $149/mobrand-name
FDAWarning letter issued to Kin Meds in February 2026. See the FDA warning-letter database.
Before enrolling
Legal entity name and state of incorporation not publicly disclosed
Desk Score
Texas-only compounded semaglutide at $149/mo with a brand Wegovy and Zepbound pathway.
- semaglutide
- $149/mopromo rate
- tirzepatide
- From $269/molowest dose rung
Before enrolling
Texas only — not available in the other 49 states
Our review of MedLeanRx gives it 69/100 (C), while our review of Kin Meds gives it 68/100 (C). The score breakdown shows where each provider does better.
Desk Score, dimension by dimension
Same six measured dimensions for both. The green bar marks the stronger score. See the methodology.
68/100
C
69/100
C
The spec sheet
Check the billing terms before comparing the figures. Our guide to paying for GLP-1 care without insurance explains how medication charges, membership fees and prepaid terms affect what you owe.
| Field | Kin Meds | MedLeanRx |
|---|---|---|
| Semaglutide | $149/mobrand-nameFull plan terms$149/mo (brand Wegovy) | $149/mopromo rateFull plan terms$149/mo (starting dose, promotional rate, compounded) |
| Tirzepatide | $149/mobrand-nameFull plan terms$149/mo (brand Zepbound) | From $269/molowest dose rungFull plan terms$269/mo (starting dose, compounded) |
| Coverage | Not confirmed for Kin Meds. | 1 state |
| Brand-name | Brand-name option listed | Brand-name option listed |
| Oral option | Oral option listed | Oral option listed |
| Best for | Compounded and brand-name GLP-1 plus a longevity stack on one platform. | Texas-only compounded semaglutide at $149/mo with a brand Wegovy and Zepbound pathway. |
| Desk Score | 68/100C | 69/100C |
The verdict
Desk pick — MedLeanRxMedLeanRx has the higher Desk Score, but Kin Meds may be a better fit if it covers your state, offers the prescribed product or has billing terms that work better for you.
Compounded and brand-name GLP-1 plus a longevity stack on one platform.
FDAWarning letter issued to Kin Meds in February 2026. See the FDA warning-letter database.
Texas-only compounded semaglutide at $149/mo with a brand Wegovy and Zepbound pathway.
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. Both compounded injections with dose-independent advertised rates. The $79 and $129 monthly equivalents require a year paid in full; confirm the total charge and refund terms.
More head-to-heads
- CoreAge Rx vs Kin Meds
- CoreAge Rx vs MedLeanRx
- Kin Meds vs Sesame Care
- MedLeanRx vs Sesame Care
- Kin Meds vs Vaylen
- MedLeanRx vs Vaylen
Or see the full comparison hub and the complete ranking.